Neuroendocrine neoplasm Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

10 events

Nov 2026A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

Bristol-Myers Squibb — PHASE4

TrialNOT YET RECRUITING

Apr 2026Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas

Roswell Park Cancer Institute — PHASE2

TrialRECRUITING

Mar 2026Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine Tumors and Unresectable Metastases: a Europe-wide Study

Insel Gruppe AG, University Hospital Bern

TrialRECRUITING

Dec 2025Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake

Akiva Mintz — PHASE2

TrialRECRUITING

Dec 2025DCEUS to Assess Treatment Response to PRRT in GEP-NET

Fondazione Policlinico Universitario Agostino Gemelli IRCCS — NA

TrialRECRUITING

Aug 2025R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

Rise Therapeutics LLC — PHASE1

TrialRECRUITING

Jun 2025Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies

Xijing Hospital — NA

TrialNOT YET RECRUITING

May 2025Risk Factors for Neuroendocrine Neoplasms

Bavarian Cancer Registry

TrialRECRUITING

May 2025A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer

Beijing GoBroad Hospital — PHASE2

TrialNOT YET RECRUITING

Apr 2025NALIRIFOX as Second-Line Chemotherapy in Extrapulmonary High-grade Neuroendocrine Neoplasms: a Prospective, Single-center, Single-arm Trial

Second Affiliated Hospital, School of Medicine, Zhejiang University — PHASE2

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Neuroendocrine neoplasm.
Check the disease page for updates →

Clinical Trial Landscape

12 active trials

1Phase 3

5Phase 2

2N/A

4Unknown

12Total recruiting

Search clinical trials for Neuroendocrine neoplasm →

Recent News & Research

No recent news articles indexed yet for Neuroendocrine neoplasm.
Search PubMed for Neuroendocrine neoplasm →

Browse all Neuroendocrine neoplasm news →

Specialist Network

Top 6 by expertise

Aaron R Mangold, M.D

Mayo Clinic

📍 SCOTTSDALE, AZ

Score 242 trials

Alberto S. Pappo, MD, M.D

Texas Children's Cancer Center

📍 MEMPHIS, TN

Score 144 trials1 pub

Urielle Desalbres

AP-HM

Score 1321 trials1 pub

Ramaprasad Srinivasan, M.D., M.D

National Cancer Institute (NCI)

📍 BETHESDA, MD

Score 136 trials

Lillian Siu, MD

Princess Margaret Hospital, Canada

Score 1213 trials

Jianming Xu

Chinese PLA General Hospital

Score 112 trials

View all Neuroendocrine neoplasm specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰